Skip to main contentSkip to navigation
Sirius Investors

SGIOF Stock: Shionogi & Co., Ltd. Stock Price, Analysis & Insights

Get live SGIOF stock price $16.00, comprehensive Shionogi & Co., Ltd. stock analysis, charts, news, and expert forecast. Real-time SGIOF stock data and investment insights.

16.00
0.00%Today
SGIOFShionogi & Co., Ltd. • Other OTC • Healthcare
Market Cap
13.62B
Volume
500
52W High
26.00
52W Low
14.25

Loading chart data...

Shionogi & Co., Ltd. (SGIOF) Overview

Shionogi & Co., Ltd. (SGIOF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, SGIOF trades at $16.00 with a market capitalization of 13.62B . Over the past 52 weeks, SGIOF has traded between $14.25 and $26.00 , with the current price positioned at approximately 15% of this range ...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 13.62B
  • Current price: $16.00
  • 52-week range: $14.25 - $26.00
  • P/E ratio: 10.67

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Shionogi & Co., Ltd. is a Japanese enterprise focused on the entire lifecycle of pharmaceutical products, diagnostic tools, and medical equipment, encompassing their investigation, creation, production, and supply within Japan. The company's marketed...

Company Information

CEO
Isao Teshirogi
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4955

Contact Information

Address
1-8, Doshomachi 3-chome
Country
JP

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 10.7)

Lower volatility stock (Beta: 0.03) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Shionogi & Co., Ltd. shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Shionogi & Co., Ltd.
  • Investors should consider how Shionogi & Co., Ltd. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

13.62B

P/E Ratio (TTM)

10.67

Beta

0.03

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.